|
|
| H-05 / Protheragen (0 Trials) |
|
| H-ferritin–nanocaged doxorubicin / Chinese Academy of Sciences, U Tokyo (0 Trials) |
|
| H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt (9 Trials) |
|
| H002 / Hongyun Biotech (0 Trials) |
|
| H003 / Carephar Pharma (0 Trials) |
|
| H1299 cell lysate with iscomatrix adjuvant vaccine / National Cancer Institute (0 Trials) |
|
| H1299 lung cancer cell lysate vaccine with Montanide ISA-51 VG adjuvant / National Cancer Institute (0 Trials) |
|
| H2Stem / Cellaion (0 Trials) |
|
| H3.3K27M Peptide Vaccine / University of California (0 Trials) |
|
| H3.3K27M TCR T cell therapy / University of California, Gilead (0 Trials) |
|
| H3B-6527 / Eisai (1 Trials) |
|
| H3B-6545 / Eisai (0 Trials) |
|
| H4 / Luhe Hospital, Chinese Academy of Sciences (0 Trials) |
|
| H4 antagonist / Sosei (0 Trials) |
|
| H4H1327P / Regeneron (0 Trials) |
|
| h5A10 / Diaprost, Radiopharm Theranostics (0 Trials) |
|
| H5N1 VLP vaccine (MT-8972) / Mitsubishi Tanabe (0 Trials) |
|
| H5NI Influenza Vaccine / iBio (0 Trials) |
|
| H7N9 Anhui 2013/AA ca / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| H7N9 vaccine (MT-7529) / Mitsubishi Tanabe (0 Trials) |
|
| HA-1 T TCR T Cell Immunotherapy / Fred Hutchinson Cancer Research Center, ElevateBio (0 Trials) |
|
| HA-irinotecan / Upstryve (1 Trials) |
|
| HA121-28 / CSPC Pharma (0 Trials) |
|
| Habeo Cell Therapy (ECCS-50) / Plus Therap (0 Trials) |
|
| Hadlima (adalimumab-bwwd) / Organon, Biogen, Samsung, Mundipharma, Yuhan Corp (2 Trials) |
|
| Haduvio (nalbuphine ER) / Trevi Therap (0 Trials) |
|
| HAE 1 (PRO 98498) / Roche (0 Trials) |
|
| Haegarda (C1 esterase inhibitor subcutaneous [human]) / CSL Behring (0 Trials) |
|
| Haemate-P (human plasma derived von Willebrand factor/FVIII complex) / CSL Behring (1 Trials) |
|
| Haemoctin (human plasma derived coagulation factor VIII) / ADMA Biologics (0 Trials) |
|
| Haemonine (human plasma derived coagulation factor IX) / ADMA Biologics (0 Trials) |
|
| Hakin-1 / University of A Coruña (0 Trials) |
|
| HAL-MPE1 / HAL Allergy (0 Trials) |
|
| Halaven (eribulin mesylate) / Eisai (69 Trials) |
|
| halcinonide / Generic mfg. (0 Trials) |
|
| Halfan (halofantrine) / GSK (0 Trials) |
|
| Haloart (halopredone) / LTT Bio-Pharma (0 Trials) |
|
| haloperidol / Generic mfg. (39 Trials) |
|
| haloperidol (CLR3001) / Clera (0 Trials) |
|
| haloperidol/trihexyphenidyl / Generic mfg. (0 Trials) |
|
| Halovirin nCov / Halo-Bio (0 Trials) |
|
| Halpryza (rituximab biosimilar) / Innovent Biologics, Eli Lilly (0 Trials) |
|
| Hamsa 1 (TL 118) / Tiltan Pharma (0 Trials) |
|
| Hamsa-1 (TL-118) / Tiltan Pharma (0 Trials) |
|
| Hamsyl (peg-aspargase biosimilar) / Emcure (0 Trials) |
|
| Hanbeitai (bevacizumab biosimilar) / Fosun Pharma (0 Trials) |
|
| Handayuan (adalimumab biosimilar) / Fosun Pharma (2 Trials) |
|
| Hanferon Oral (interferon alpha-2b oral) / Daewoong Pharma (0 Trials) |
|
| Hanferon SC (interferon alpha-2b) / Daewoong Pharma (0 Trials) |
|
| Hanlikang (rituximab biosimilar) / Fosun Pharma, Eurofarma, AbbVie, Farma de Colombia (3 Trials) |
|
| HANP (carperitide) / Zeria Pharma, Daiichi Sankyo (0 Trials) |
|
| Hansizhuang (serplulimab) / Fosun Pharma (0 Trials) |
|
| Hansoh Xinfu (flumatinib) / Jiangsu Hengrui Pharma, Jiangsu Hansoh Pharma (10 Trials) |
|
| HAPC1573 / Bayer, Shanghai RAAS (0 Trials) |
|
| haploid allogeneic NK cell therapy / iCELL Biotechnology (0 Trials) |
|
| Haruropi tape (ropinirole transdermal) / Hisamitsu, Kyowa Kirin (0 Trials) |
|
| Havrix (hepatitis A vaccine, inactivated) / GSK (0 Trials) |
|
| HB-001 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB-002 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB-1 / Honeybrains Biotech (0 Trials) |
|
| HB-101 / Hookipa Pharma (0 Trials) |
|
| HB-110E / Genexine (0 Trials) |
|
| HB-121 / Healion Bio (0 Trials) |
|
| HB-200 / Hookipa Pharma (0 Trials) |
|
| HB-201 / Hookipa Pharma (0 Trials) |
|
| HB-300 / Hookipa Pharma (0 Trials) |
|
| HB-400 / Gilead, Hookipa Pharma (0 Trials) |
|
| HB-500 / Hookipa Pharma, Gilead (0 Trials) |
|
| HB-700 / Hookipa Pharma, Roche (0 Trials) |
|
| HB-adMSC / Hope Biosciences (0 Trials) |
|
| HB-AS 02 / GSK (1 Trials) |
|
| HB0017 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB002.1M / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0025 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0028 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0030 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0034 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0036 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0039 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0043 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0045 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0052 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB007 / HB Therap (0 Trials) |
|
| HBI 0201-ESO TCRT / Hadassah Medical Organization (0 Trials) |
|
| HBI-2375 / HUYA Bioscience (0 Trials) |
|
| HBI-2376 / HUYA Bioscience (0 Trials) |
|
| HBI-2438 / HUYA Bioscience (0 Trials) |
|
| HBI-ONC / HUYA Bioscience (0 Trials) |
|
| hBM-MSC / Translational Research Center for Medical Innovation (0 Trials) |
|
| HBM1007 / Harbour BioMed (0 Trials) |
|
| HBM1020 / Harbour BioMed (0 Trials) |
|
| HBM1022 / Harbour BioMed (0 Trials) |
|
| HBM1029 / Harbour BioMed (0 Trials) |
|
| HBM1039 / Harbour BioMed (0 Trials) |
|
| HBM1040 / Harbour BioMed (0 Trials) |
|
| HBM1047 / Harbour BioMed (0 Trials) |
|
| HBM1053 / Harbour BioMed (0 Trials) |
|
| HBM7004 / Harbour BioMed (0 Trials) |
|
| HBM7008 / Harbour BioMed, Cullinan Oncology (0 Trials) |
|
| HBM7015 / Harbour BioMed (0 Trials) |
|
| HBM7020 / Harbour BioMed, Hualan Biological Engineering (0 Trials) |
|
| HBM7021 / Harbour BioMed (0 Trials) |
|
| HBM7023 / Harbour BioMed (0 Trials) |
|
| HBM7024 / Harbour BioMed (0 Trials) |
|
| HBM7025 / Harbour BioMed (0 Trials) |
|
| HBM9001 / Sichuan Kelun Pharma, Harbour BioMed (0 Trials) |
|
| HBM9022 / Utrecht University, Erasmus MC, Harbour BioMed, AbbVie (0 Trials) |
|
| HBM9027 / Harbour BioMed (0 Trials) |
|
| HBM9033 / Harbour BioMed (0 Trials) |
|
| HBP-bound-doxorubicin (12B80) / Atlanthera (0 Trials) |
|
| HBS-102 / Paragon Biosci (0 Trials) |
|
| HBV surface antigen secretion inhibitors / Arbutus (0 Trials) |
|
| HBV therapeutic vaccine / IMV Inc (0 Trials) |
|
| HBV vaccine / ProMed BioSci (0 Trials) |
|
| HBVaxPro (hepatitis-B vaccine (rDNA)) / Merck (MSD), Sanofi (0 Trials) |
|
| HBW-3-10 / Hyperway Pharma (0 Trials) |
|
| HBW-3-20 / Hyperway Pharma (0 Trials) |
|
| HBW-3090 / Hyperway Pharma (0 Trials) |
|
| HC-5404 / HiberCell (0 Trials) |
|
| HC-7366 / HiberCell (0 Trials) |
|
| HC-X014 / Hinova Pharma (0 Trials) |
|
| HC-X027 / Hinova Pharma (0 Trials) |
|
| HC-X029 / Hinova Pharma (0 Trials) |
|
| HC-X035 / Hinova Pharma (0 Trials) |
|
| HCB101 / HanchorBio (0 Trials) |
|
| HCB1019 / OcuNexus (0 Trials) |
|
| hCD19 CAR-T cells / Affiliated Hospital of Xuzhou Medical University (0 Trials) |
|
| HCI-1046 / Biolexis Therap (0 Trials) |
|
| HCI-1401 / HLB Bio Group (0 Trials) |
|
| HCP1803 / Hanmi (0 Trials) |
|
| HCP1904 / Hanmi (0 Trials) |
|
| HCP2102 / Hanmi (0 Trials) |
|
| HCR040 / Noray (0 Trials) |
|
| hCT-MSC / Duke University (0 Trials) |
|
| HCV E1E2/MF59C / Novartis (0 Trials) |
|
| HCV vaccine / VBI Vaccines (0 Trials) |
|
| HCVax (lentiviral based HCV immunotherapy) / GeneCure Biotechnologies (0 Trials) |
|
| HCW9207 / HCW Biologics (0 Trials) |
|
| HCW9218 / HCW Biologics (0 Trials) |
|
| HCW9302 / HCW Biologics (0 Trials) |
|
| HD-003 / Hyundai Pharm (0 Trials) |
|
| HD-6277 / Hyundai Pharm (0 Trials) |
|
| HD-7671 / Hyundai Pharm (0 Trials) |
|
| HD-CAR-1 / Heidelberg University Hospital (0 Trials) |
|
| HD205 / Hanwha Solutions (0 Trials) |
|
| HDAC inhibitor / Alkermes (0 Trials) |
|
| HDDO-1756 / Hyundai Pharm (0 Trials) |
|
| HDIT101 / Heidelberg ImmunoTherap (0 Trials) |
|
| HDL receptor enhancer / Abionyx Pharma (0 Trials) |
|
| HDM-SPIRE / Circassia (0 Trials) |
|
| HDP-101 / Heidelberg Pharma (1 Trials) |
|
| HDP-102 / Heidelberg Pharma (0 Trials) |
|
| HDP-103 / Heidelberg Pharma (0 Trials) |
|
| HDP-104 / Heidelberg Pharma (0 Trials) |
|
| HDV insulin lispro (HDV-L) / Diasome (0 Trials) |
|
| HDV-interferon (interferon alpha controlled-release) / Hepasome Pharma (0 Trials) |
|
| HE-33 / Immune Modulation (0 Trials) |
|
| HE3177 / Harbor Biosci (0 Trials) |
|
| HE3413 / Harbor Biosci (0 Trials) |
|
| head and neck cancer vaccine / Vyriad (0 Trials) |
|
| Healive (Hepatitis A vaccine inactivated) / Sinovac (0 Trials) |
|
| Heartcel (iMP cell therapy) / Celixir (0 Trials) |
|
| Hearticellgram-AMI (Autologous bone marrow derived mesenchymal stem cells) / Pharmicell (0 Trials) |
|
| Heberitro (epoetin alfa biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| HeberNasvac (ABX203) / Center for Genetic Engineering and Biotechnology, Abivax (0 Trials) |
|
| HEBERSaVax (CIGB-247) / Center for Genetic Engineering and Biotechnology, Heber Biotec (0 Trials) |
|
| Hebervital (filgrastim biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| HEC-016 / Shenzhen Fifth People's Hospital (0 Trials) |
|
| HEC116094 / HEC Pharm (0 Trials) |
|
| HEC121120 / HEC Pharm (0 Trials) |
|
| HEC122505MsOH / HEC Pharm (0 Trials) |
|
| HEC137076MsOH / HEC Pharm (0 Trials) |
|
| HEC169096 / HEC Pharm (0 Trials) |
|
| HEC53856 / HEC Pharm (0 Trials) |
|
| HEC68498 / HEC Pharm (0 Trials) |
|
| HEC73077 / HEC Pharm (0 Trials) |
|
| HEC80797 / HEC Pharm (0 Trials) |
|
| HEC83518 / HEC Pharm (0 Trials) |
|
| HEC89736 / HEC Pharm (0 Trials) |
|
| HEC96719 / HEC Pharm (0 Trials) |
|
| Hecolin (recombinant hepatitis E vaccine) / Wantai BioPharm (0 Trials) |
|
| Heliocare (polypodium leucotomos extract) / Ferndale (0 Trials) |
|
| Helios ocular insert (bimatoprost sustained release insert) / AbbVie (0 Trials) |
|
| Helix Partner-02 / BioCardia (0 Trials) |
|
| Hemady (dexamethasone tablets) / Dexcel Pharma (0 Trials) |
|
| HemaMax (rHuIL-12) / Karyopharm, Libo Pharma (2 Trials) |
|
| Hemapo (epoetin alfa biosimilar) / PT Kalbe Farma, Alliance, CIMAB (0 Trials) |
|
| Hemaseel HMN (fibrin sealant) / Haemacure (0 Trials) |
|
| hematologic Tumor Accurin / Pfizer (0 Trials) |
|
| Hemay007 / Tianjin Hemay Pharma (0 Trials) |
|
| Hemay022 / Tianjin Hemay Pharma (3 Trials) |
|
| Hemay808 / Tianjin Hemay Pharma (0 Trials) |
|
| Hemgenix (etranacogene dezaparvovec) / CSL Behring (0 Trials) |
|
| Hemlibra (emicizumab-kxwh) / Roche (22 Trials) |
|
| Hemo-8r (recombinant coagulation factor VIII) / Hemobras (0 Trials) |
|
| HEMO-CAR-T / Hemogenyx, University of Pennsylvania (0 Trials) |
|
| Hemodynamic modulator / Boehringer Ingelheim (0 Trials) |
|
| Hemofil-M (human plasma derived coagulation factor VIII) / Takeda (0 Trials) |
|
| hemophilia A cell therapy / Sernova (0 Trials) |
|
| hemophilia A lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
|
|